Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQR0E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,555
Award facts
- Contract value 100% obligated
- $87,555.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $87,555.42 on November 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). The contract is firm fixed price with no set-aside designation and is scheduled for completion by December 19, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The company's pharmaceutical prime vendor contract with DLA represents a comprehensive global support vehicle enabling flexible and responsive medical supply fulfillment for defense healthcare programs worldwide. This delivery order for Vyndamax, a medication used in the treatment of transthyretin amyloidosis, exemplifies the company's ongoing role in providing specialized pharmaceutical products to federal healthcare customers through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26FQR0E?
SPE2DR26FQR0E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FQR0E worth?
The government has obligated $87,555 on SPE2DR26FQR0E.
Is contract SPE2DR26FQR0E an order under another contract?
Yes. SPE2DR26FQR0E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR0E competed?
The extent of competition for SPE2DR26FQR0E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award